nanoDot Dosimeters Research Articles

Visualization of spatial dose distribution for effective radiation protection education in interventional radiology: obtaining high-accuracy spatial doses.

In recent years, eye lens exposure among radiation workers has become a serious concern in medical X-ray fluoroscopy and interventional radiology (IVR), highlighting the need for radiation protection education and training. This study presents a method that can maintain high accuracy when calculating spatial dose distributions obtained via Monte Carlo simulation and establishes another method to three-dimensionally visualize radiation using the obtained calculation results for contributing to effective radiation-protection education in X-ray fluoroscopy and IVR. The Monte Carlo particle and heavy ion transport code system (PHITS, Ver. 3.24) was used for calculating the spatial dose distribution generated by an angiography device. We determined the peak X-ray tube voltage and half value layer using Raysafe X2 to define the X-ray spectrum from the source and calculated the X-ray spectrum from the measured results using an approximation formula developed by Tucker et al. Further, we performed measurements using the "jungle-gym" method under the same conditions as the Monte Carlo calculations for verifying the accuracy of the latter. An optically stimulated luminescence dosimeter (nanoDot dosimeter) was used as the measuring instrument. In addition, we attempted to visualize radiation using ParaView (version 5.12.0-RC2) using the spatial dose distribution confirmed by the above calculations. A comparison of the measured and Monte Carlo calculated spatial dose distributions revealed that some areas showed large errors (12.3 and 24.2%) between the two values. These errors could be attributed to the scattering and absorption of X-rays caused by the jungle gym method, which led to uncertain measurements, and (2) the angular and energy dependencies of the nanoDot dosimetry. These two causes explain the errors in the actual values, and thus, the Monte Carlo calculations proposed in this study can be considered to have high-quality X-ray spectra and high accuracy. We successfully visualized the three-dimensional spatial dose distribution for direct and scattered X-rays separately using the obtained spatial dose distribution. We established a method to verify the accuracy of Monte Carlo calculations performed through the procedures considered in this study. Various three-dimensional spatial dose distributions were obtained with assured accuracy by applying the Monte Carlo calculation (e.g., changing the irradiation angle and adding a protective plate). Effective radiation-protection education can be realized by combining the present method with highly reliable software to visualize dose distributions.

Developing methodology to evaluate eye lens dose for medical staff

Due to epidemiological evidence on the increasing incidence of cataracts in interventional doctors, The International Commission on Radiological Protection (ICRP) recommended decreasing the eye lens dose limit from 150 mSv/year to 20 mSv/year. Thus, The current status of dose assessment for healthcare workers shows that it requires more precise measurements of eye lens dose. we have researched Investigating dosimetric characteristics of OSLD nanoDot and Inlight type, using a multi–filter technique to determine the average air kerma of the incident beam and other essential dosimetric factors such as the relative energy responses and conversion coefficients from the air kerma to personal dose equivalent operational quantities Hp(d). Based on it developed the methodologies to evaluate eye lens dose for medical staff, especially high-risk subjects such as interventional doctors. Results show that 3 methods to evaluate eye lens dose have been deployed in the cardiovascular intervention department: directly by nanoDot dosimeter, indirectly by personal dosimeter (Inlight), and quick method based on the relationship with exposure duration. In one case, the doctor exceeded the threshold dose of 20 mSv/year without protective measures. Besides that, the risk of cataracts is possible when considering the cumulative dose for 30 years of work.

Assessment of organ doses from head and neck cone-beam computed tomography (CBCT) in adaptive radiation therapy: A phantom study

The purpose of this study was to estimate accumulated organ doses from cone-beam computed tomography (CBCT) in adaptive radiation therapy (ART) of head and neck cancer treated with Ethos linear accelerators (linacs) using the nanoDot detectors in the rando phantom. The nanoDot dosimeter was placed on the Rando phantom for experimental measurement. The measurement was performed during kilovoltage cone-beam computed tomography (kV-CBCT) image acquisition in Ethos linac (Varian Medical Systems, Pala Alto, CA, USA). Consequently, the absorbed dose at organ was estimated using depth correction factor and mass attenuation coefficient ratio between each organ and air ((μenρ)tissue(μenρ)air). The result has showed that an absorbed dose at lens, thyroid gland, and parotid glands was lower than the dose limit of ICRP 103 guideline. The range of absorbed doses was 0.36–1.17 mGy for left eye lens, 0.36–1.63 mGy for right eye lens, 3.00–3.20 mGy left lobe thyroid, 2.69–2.87 mGy for right lobe thyroid, 2.19–2.32 mGy for left lobe parotid, and 1.92–2.01 mGy for right lobe parotid. The result of accumulated dose estimation was determined for 33 fractions which was 35.1, 32.3, 46.0, 39.8, 63.2, and 56.7 mGy for left lens, right lens, left parotid, right parotid, left lobe thyroid, and right lobe thyroid, respectively. Although the organ doses received from daily CBCT images were less than those from radiation treatment, it should be a concern when the dose at OARs is near the limitation in the treatment planning process.

Whole body and extremity doses of nuclear medicine personnel involved in manual and semi-automated methods of dispensing liquid iodine-131

This study aimed to evaluate the whole body dose Hp (10) and extremity dose Hp (0.07) of nuclear medicine personnel who administered liquid I-131 by using manual and fabricated semi-automated dispenser system. The semi-automated dispenser system comprises of peristaltic pumps and a motor controller was developed for dispensing liquid I-131. Optically stimulated luminescent dosimeters (OSLD) were used on two radiopharmacists to evaluate the whole body dose HP (10). NanoDot dosimeters were placed on personnel fingers to measure extremity dose HP (0.07). The mean doses were calculated for both manual and automated dispensing techniques. The findings revealed a significant 87.65%–92.31% reduction in both whole body and extremity doses when utilising semi-automated dispenser system compared to manual dispensing. Additionally, the semi-automated dispenser system demonstrated high accuracy with ≤5% error in dispensing the prescribed amount of liquid I-131. The use of the semi-automated system resulted in a significant reduction in whole body and extremity doses due to less contact between personnel and the source, and high accuracy of the prescribed amount of I-131.

Entrance Skin Dose (ESD) and Bucky Table Induced Backscattered Dose (BTI-BSD) in Abdominal Radiography With nanoDot Optically Stimulated Luminescence Dosimeter (OSLD).

In radiography, inconsistencies in patients' measured entrance skin dose (ESD) exist. There is no published research on the bucky table induced backscattered radiation dose (BTI-BSD). Thus, we aimed to ascertain ESD, calculate the BTI-BSD in abdominal radiography with a nanoDot OSLD, and compare the ESD results with the published data. A Kyoto Kagaku PBU-50 phantom (Kyoto, Japan)in an antero-posterior supine position was exposed, selecting a protocol used for abdominal radiography. The central ray of x-ray beam was pointed at the surface ofabdomen at the navel, where a nanoDot dosimeter was placed to measure ESD. For the BTI-BSD, exit dose (ED) was determined by placing a second dosimeter on the exact opposite side (backside) of the phantom from the dosimeter used to determine (ESD) with and without bucky table at identical exposure parameters. The BTI-BSD was calculated as the difference between ED with and without bucky table. The ESD, ED, and BTI-BSD were measured in milligray (mGy). ESD mean values with and without bucky table were 1.97 mGy and 1.84 mGy, whereas ED values were 0.062 mGy and 0.052 mGy, respectively. Results show 2-26% lowerESD values with nanoDot OSLD. The BTI-BSD mean value was found to be approximately 0.01 mGy. A local dose reference level (LDRL) can be established using ESD data to safeguard patients from unnecessary radiation. In addition, to minimize the risk of BTI-BSD in patients in radiography, the search for the use or fabrication of a new, lower atomic number material for the bucky table is suggested.

Protocol determination for OSL in vivo measurements of absorbed dose in the oral mucosa in oral cancer patients: A pilot study

Radiation-induced oral mucositis (RIOM) is one of the major oral complications caused by radiotherapy (RT), and can lead a negative impact on patients’ quality of life. Considering that there is no specific radiation therapy dose constraint for oral mucosa, the need to study the correlation between absorbed dose and effect in this area is crucial. This pilot study aims to report in vivo OSL dosimetry protocol to investigate the dose distribution in the oral mucosa in patients with oral cancer using Intraoral customised Stent (IOS). For measurements, aluminium oxide nanoDot dosimeters and a microStar ii OSL reader from Landauer Inc. were used. The OSL dosimetry system was calibrated with a 6 MV photon beam using an Elekta Synergy linear accelerator and solid water phantoms following the recommendations of the AAPM TG 191 protocol. The dose distribution in the oral mucosa using seven OSL dosimeters fixed on the intraoral stent was evaluated and compared with the dose distribution available from the RT planning for the patient. Our experimental results showed the expected linearity response of the nanoDot dosimeters from 20 to 200 cGy. The repeatability of readings was better than 1.0% in all commissioning measurements. The uncertainty budget of the commissioning analysis resulted in an overall type An uncertainty of ∼3.4% at the 1-sigma level for dose calculation, compatible with the TG 191 protocol. The dose distribution in the oral mucosa was assessed and dose deviations up to 35% can be found in high dose gradient regions of the treatment planning. This type of deviation may impact on the development and progression of RIOM, as analysed in this protocol. It is feasible to establish this procedure in vivo dosimetry for a patient undergoing RT using a multidisciplinary approach. Additionally, intraoral customised stents can decrease radiation doses in the oral mucosa, and the understanding of the dose distribution in the oral mucosa may help to minimise damages from radiation.

Measurement of conversion factor into mean glandular dose in mammography using OSL dosimeters

Background: Currently, the DRL quantity in mammography are evaluated in terms of mean glandular dose (MGD). Since the MGD cannot be measured directly, it can be obtained by calculation using the equation (D=K*g*c*s). In previous studies, the conversion factor g was calculated by Monte Carlo simulation and is not reported from actual measurements. In this study, we focused on the g-factor, which is a conversion factor to the MGD at 50% glandularity, and attempted to measure it using a nanoDot dosimeter to see if it can be used in mammography. Methods: The nanoDot dosimeters were inserted in a PMMA phantom at depths ranging from 0 cm to 6 cm in 1 cm increments, and measurements were made in three HVLs of 0.3 mmAl, 0.35 mmAl, and 0.4 mmAl HVL. The g-factor was calculated from the nanoDot dosimeter values using a conversion equation. Results and Discussion: The measured g-factors for all the HVLs were in close agreement with those of Dance et al. The values of the previous studies did not include the backscatter factor, which may have underestimated the MGD. The difference was smaller for the 0.4 mm Al. Compared to the other HVLs, the 0.4 mm Al was measured without a compression plate, which may have been influenced by the presence or absence of a compression plate. Conclusion: The nanoDot dosimeters were used to calculate g-factors. The results agreed with those of previous studies within uncertainty. This indicates that nanoDot dosimeters can be used in the mammography field.

Determination of a reliable assessment for occupational eye lens dose in nuclear medicine.

The most recent statement published by the International Commission on Radiological Protection describes a reduction in the maximum allowable occupational eye lens dose from 150 to 20 mSv/year (averaged over 5‐year periods). Exposing the eye lens to radiation is a concern for nuclear medicine staff who handle radionuclide tracers with various levels of photon energy. This study aimed to define the optimal dosimeter and means of measuring the amount of exposure to which the eye lens is exposed during a routine nuclear medicine practice. A RANDO human phantom attached to Glass Badge and Luminess Badge for body or neck, DOSIRIS and VISION for eyes, and nanoDot for body, neck, and eyes was exposed to 99mTc, 123I, and 18F radionuclides. Sealed syringe sources of each radionuclide were positioned 30 cm from the abdomen of the phantom. Estimated exposure based on measurement conditions (i.e., air kerma rate constants, conversion coefficient, distance, activity, and exposure time) was compared measured dose equivalent of each dosimeter. Differences in body, neck, and eye lens dosimeters were statistically analyzed. The 10‐mm dose equivalent significantly differed between the Glass Badge and Luminess Badge for the neck, but these were almost equivalent at the body. The 0.07‐mm dose equivalent for the nanoDot dosimeters was greatly overestimated compared to the estimated exposure of 99mTc and 123I radionuclides. Measured dose equivalents of exposure significantly differed between the body and eye lens dosimeters with respect to 18F. Although accurately measuring radiation exposure to the eye lenses of nuclear medicine staff is conventionally monitored using dosimeters worn on the chest or abdomen, eye lens dosimeters that provide a 3‐mm dose equivalent near the eye would be a more reliable means of assessing radiation doses in the mixed radiation environment of nuclear medicine.

SABR pre-treatment checks using alanine and nanoDot dosimeters.

Stereotactic Ablative Radiotherapy (SABR) remains one of the preferred treatment techniques for early-stage cancer. It can be extended to more treatment locales involving the sternum, scapula and spine. This work investigates SABR checks using Alanine and nanoDot dosimeter for three treatment sites, including sternum, spine and scapula. Alanine and nanoDot dosimeters' performances were verified using a 6 MV photon beam before SABR pretreatment verifications. Each dosimeter was placed inside customized designed inserts into a Rod Phantom (in-house phantom) made of Perspex that mimics the human body for a SABR check. Electron Paramagnetic Resonance (EPR) spectrometer, Bruker EleXsys E500 (9.5GHz) and Microstar (Landauer Inc.) Reader was employed to acquire the irradiated alanine and nanoDot dosimeters' signal, respectively. Both dosimeters treatment sites are expressed as mean ± standard deviation (SD) of the measured and Eclipse calculated dose Alanine (19.59 ± 0.24, 17.98 ± 0.15, 17.95 ± 0.18) and nanoDot (19.70 ± 0.43, 17.05 ± 0.08, 17.95 ± 0.98) for spine, scapula and sternum, respectively. The percentage difference between alanine and nanoDot dosimeters was within 2% for sternum and scapula but 2.4% for spine cases. These results demonstrate Alanine and nanoDot dosimeters' potential usefulness for SABR pretreatment quality assurance (QA).

Investigation of backscatter factor in medical radiography using anthropomorphic phantom by optically stimulated luminescence dosimeter

At the diagnostic reference level (DRL) related to medical radiation, DRL quantity for general radiography is the entrance surface dose (ESD). Calculation of the ESD in medical radiography requires the backscatter factor (BSF), but derivation of the BSF requires assessment of an irradiated simulation of a human body. The present study used optically stimulated luminescence (OSL) dosimeters and an anthropomorphic phantom as the irradiated body, and the BSF was calculated for different half value layer (HVL)s and field sizes. The need for different BSFs for different regions was also investigated by derivationing of the BSFs for different regions. The pelvis of a RANDO phantom was irradiated under the conditions of the HVL of 2.0, 3.1, and 4.6 mmAl; tube current of 200 mA; irradiation time of 0.1 s; source surface distance of 100 cm; and field sizes of 10 × 10 cm2, 20 cm2, 30 cm2, and 40 cm2. Measurement in air was performed under the same conditions. Several threads were stretched through the air with tissue paper placed on them and the nanoDot dosimeters placed on the paper. Four dosimeters were placed, and measurement was performed 5 times under each set of conditions. The compared radiographed regions were the skull, chest, and pelvis. The BSF increased with increasing HVL size and with increasing field size. The larger the HVL, the larger the difference between field sizes of 10 × 10 cm2 and 40 × 40 cm2 and the larger the increase in BSF relative to the increase in field size. The BSF differed by region, from large to small in the order chest, pelvis, and skull. The results thus showed that the BSF differs by the radiographed region. Thus, it is desirable to determine the BSF in each radiographed region by investigation with an anthropomorphic phantom.

Study on electronic equilibrium of 137Cs gamma radiation for 3D printed phantoms using OSL dosimetry

With the popularization of 3D printing technologies, it is now possible to develop patient specific simulators and various other accessories using this technology in medical physics and dosimetry. This work aims to evaluate the electronic equilibrium of 3D printed phantoms using PLA and ABS filaments compared to PMMA for 137Cs gamma rays using OSL dosimetry. A Landauer microStar ii commercial OSL system was commissioned and it was used nanoDot dosimeters. Phantom plates with 2.5, 3.0 and 5.0 mm thickness were used to obtain electronic equilibrium for 137Cs gamma rays. Measurements were compared with PMMA measurements at standard conditions. Results show that measurements with ABS and PLA thicknesses of 2.5 and 3.0 mm presents dosimetry results within irradiation uncertainty. More accuracy is obtained using 3.0 mm for both PLA and ABS phantoms, with differences in less than 0.5%. It can be concluded that PLA and ABS 3D phantom plates has similar properties of PMMA for 137Cs gamma rays dosimetry and can be used for developing dosimetry accessories for this energy photon beam.

Use of Commercially Available Optically Stimulated Luminescence Dosimeter As Extremity Dose Estimator.

In 2009, Idaho National Laboratory (INL) transitioned to an external dosimetry program using optically stimulated luminescent (OSL) technology. This process led to the introduction of the Landauer, Inc., nanoDot dosimeter and MicroStar reader to INL's radiological control program. At the time, a small, self-contained, single chip OSL dosimeter that could be easily read in the field was recognized as having many potential applications for a radiological control program. The ability to achieve a realistic extremity-dose estimate in the field shortly following work where significant exposure is expected is a much sought-after capability at INL. It was proposed to employ the Landauer nanoDot dosimeter as a supplemental extremity monitor as an alternative to time-motion dose analyses based on direct radiation measurements, which had proven to be inaccurate and operationally inefficient. Additionally, this process does not involve the nanoDot in the US Department of Energy Laboratory Accreditation Program (DOELAP) process, which significantly reduces operational complexity. A dose conversion value for the nanoDot dosimeter was derived from direct comparisons with a DOELAP-accredited extremity dosimeter. The geometry or placement of the nanoDot relative to the accredited extremity dosimeter was kept as proximate as possible to best replicate the expected results from the accredited extremity dosimeter. Upon implementation, the nanoDot has proven to be effective in providing reasonable and timely extremity-dose estimates for operational control.

Application of OSL dosimetry and 3D printed phantom for comparison of calculation algorithms for VMAT treatment planning

The application of new commercial and industrial technologies in the fields of dosimetry and medical physics is of great interest to the scientific community, both to validate existing protocols and to develop new methodologies. The popularization of 3D printing techniques has been analyzed as a great advantage in quality control in complex treatment techniques, such as radiotherapy and the development of patient simulators. Portable dosimetry systems such as Landauer MicroStar OSL system are versatile and their use in quality control is of great importance. The aim of this paper is to compare two of the most used dose calculation algorithms used in Varian Eclipse TPS – AAA and Acuros XB – for treatment planning of multiple brain metastases using a 3D printed anthropomorphic phantom and the OSL InLight system for experimental dosimetry validation. A 3D printed anthropomorphic skull phantom was submitted to a CT scan and planed five target volumes. In order of comparison, two dose calculations were performed in the Varian Eclipse 13.6 TPS with "Alabama technique", using the Varian’s AAA and AXB algorithms, and treatment delivered with 6 MV photon beam of a Varian TrueBeam linear accelerator. Landauer nanoDot dosimeters were positioned inside each of the five target volumes planned and the experimental dosimetric results were compared with the algorithms’ calculated doses. The findings of this work indicate that ACUROS XB calculates more accurate doses compared with AAA, with all the experimental agreements better than 96.0 %, probably because of the heterogeneity corrections. The uncertainty analysis of the InLight system device is enough to sustain the dosimetric uncertainties below 3.0 %, validating the results.

Investigation and Implementation of Commercially Available Optically Stimulated Luminescence Dosimeters for Use in Fixed Nuclear Accident Dosimeter Systems.

Idaho National Laboratory transitioned from an external dosimetry system reliant on thermoluminescent dosimeters to one that uses optically stimulated luminescence dosimeters in 2010. This change not only affected the dosimeters worn by personnel, but those found in the nuclear-accident dosimeters used across Idaho National Laboratory. The elimination of on-site use and processing of thermoluminescent dosimeters impacted Idaho National Laboratory's ability to process nuclear-accident dosimeters in a timely manner. This change in processes drove Idaho National Laboratory to develop an alternative method for fixed nuclear-accident dosimeter gamma-dose analyses. This new method was driven by the need to establish a simple, cost-effective, and rapid-turnaround alternative to the thermoluminescent-dosimeter-based fixed nuclear-accident dosimeter system. An adaptation of existing technologies proved to be the most efficient path to this end. The purpose of this article is to delineate the technical basis for replacing the thermoluminescent dosimeter contained within the Idaho National Laboratory fixed nuclear-accident dosimeter system with optically stimulated luminescence-based Landauer, Inc., nanoDot dosimeters.

Physical validation of UF-RIPSA: A rapid in-clinic peak skin dose mapping algorithm for fluoroscopically guided interventions.

PurposeThe purpose of this study was to experimentally validate UF‐RIPSA, a rapid in‐clinic peak skin dose mapping algorithm developed at the University of Florida using optically stimulated luminescent dosimeters (OSLDs) and tissue‐equivalent phantoms.MethodsThe OSLDs used in this study were InLightTM Nanodot dosimeters by Landauer, Inc. The OSLDs were exposed to nine different beam qualities while either free‐in‐air or on the surface of a tissue equivalent phantom. The irradiation of the OSLDs was then modeled using Monte Carlo techniques to derive correction factors between free‐in‐air exposures and more complex irradiation geometries. A grid of OSLDs on the surface of a tissue equivalent phantom was irradiated with two fluoroscopic x ray fields generated by the Siemens Artis zee bi‐plane fluoroscopic unit. The location of each OSLD within the grid was noted and its dose reading compared with UF‐RIPSA results.ResultsWith the use of Monte Carlo correction factors, the OSLD's response under complex irradiation geometries can be predicted from its free‐in‐air response. The predicted values had a percent error of −8.7% to +3.2% with a predicted value that was on average 5% below the measured value. Agreement within 9% was observed between the values of the OSLDs and RIPSA when irradiated directly on the phantom and within 14% when the beam first traverses the tabletop and pad.ConclusionsThe UF‐RIPSA only computes dose values to areas of irradiated skin determined to be directly within the x ray field since the algorithm is based upon ray tracing of the reported reference air kerma value, with subsequent corrections for air‐to‐tissue dose conversion, x ray backscatter, and table/pad attenuation. The UF‐RIPSA algorithm thus does not include the dose contribution of scatter radiation from adjacent fields. Despite this limitation, UF‐RIPSA is shown to be fairly robust when computing skin dose to patients undergoing fluoroscopically guided interventions.

Eye lens dosimetry and the study on radiation cataract in interventional cardiologists

PurposeTo determine the eye lens dose of the Interventional Cardiology (IC) personnel using optically stimulated luminescent dosimeter (OSLD) and the prevalence and risk of radiation – associated lens opacities in Thailand. Methods and results48 IC staff, with age- and sex- matches 37 unexposed controls obtained eye examines. Posterior lens change was graded using a modified Merriam-Focht technique by two independent ophthalmologists. Occupational exposure (mSv) was measured in 42 IC staff, using 2 OSLD badges place at inside lead apron and at collar. Annual eye lens doses (mSv) were also measured using 4 nanoDots OSL placed outside and inside lead glass eyewear. The prevalence of radiation-associated posterior lens opacities was 28.6% (2/7) for IC, 19.5% (8/41) for nurses, and 2.7% (1/37) for controls. The average and range of annual whole body effective dose, Hp(10), equivalent dose at skin of the neck, Hp(0.07) and equivalent dose at eye lens, Hp(3) were 0.80 (0.05–6.79), 5.88 (0.14–35.28), and 5.73 (0.14–33.20) mSv respectively. The annual average and range of eye lens dose using nano Dots OSL showed the outside lead glass eyewear on left and right sides as 8.06 (0.17–32.45), 3.55(0.06–8.04) mSv and inside left and right sides as 3.91(0.05–14.26) and 2.44(0.06–6.24) mSv respectively. ConclusionEye lens doses measured by OSLD badges and nano Dot dosimeter as Hp(10), Hp(0.07) and Hp(3). The eyes of the IC personnel were examined annually by two ophthalmologists for the prevalence of cataract induced by radiation.

Introduction of optically stimulated luminescence based postal audits for radiation protection level dosimetry at Secondary Standard Dosimetry Laboratories

The IAEA has introduced an Optically Stimulated Luminescence Dosimetry (OSLD) system to conduct postal audits to Secondary Standard Dosimetry Laboratories (SSDLs) for radiation protection level. The audit independently checks 137Cs radiation protection air kerma calibrations provided by the SSLDs. The OSLD system has replaced the previously used TLD based audit for radiation protection.The OSLD system used in the audit consists of nanoDot dosimeters and MicroSTARii reader (Landauer, IL, USA). Prior to introducing the audit service, an extensive commissioning process quantified the dosimeter reading reproducibility, signal depletion and fading, linearity of response to air kerma, individual sensitivities of OSLDs and optical annealing procedure for the dosimeters. In an audit run, the participating SSLDs are supplied with two dosimeter sets consisting of two lightweight holders each preloaded with two OSLDs. The participants are asked to irradiate them with 5 mGy air kerma free in air, following their standard laboratory procedures. The OSLDs returned to the IAEA are evaluated by the IAEA Dosimetry Laboratory.The OSLDs demonstrated acceptable reading reproducibility of 1.75% and a signal depletion of 0.25% per readout. The OSLDs signal fading resulted in a signal decrease of 2.1% in the period from eight days to over 160 days post irradiation. A relative expanded (k = 2) uncertainty of the OSLD determined air kerma was estimated to 3.08%. In two audit runs in 2015–2016, 29 SSDLs participated. The average ratio of the air kerma measured by the IAEA to the air kerma stated by the SSDL was 0.998 and the standard deviation of the distribution of results was 1.8%. All participants except one had results within the acceptance limits of ±7%. One laboratory with the result outside the acceptance limit was invited to a follow-up procedure with the aim to resolve the discrepancy.

Application of optically stimulated luminescence ‘nanoDot’ dosimeters for dose verification of VMAT treatment planning using an anthropomorphic stereotactic end-to-end verification phantom

This paper aims to evaluate the performance of the commercial OSL Landauer InLight System to be applied in dosimetric measurements in a Volumetric Modulated Arc (VMAT) brain tumor planning treatment using a Stereotactic End-To-End Verification Phantom Patient (STEEV™ – CIRS), comparing its results with CaSO4:Dy TLD pellets manufactured and marketed by the Laboratory of Dosimetric Materials/IPEN, PTW PinPoint™ ion chamber and Eclipse 10.0 planning system. The results of commercial InLight™ System using the nanoDot dosimeters showed good reproducibility and stability in both laboratory and clinical measurements. The experimental dose values obtained by all dosimetric techniques varied less than ±1.0% from prescribed by Eclipse 10.0. The intrinsic precision and uncertainty of the OSL reading device were found fair enough, providing good experimental results for VMAT dosimetry.

Response of Nanodot Optically Stimulated Luminescence Dosimeters to Therapeutic Electron Beams.

Response of Al2O3:C-based nanoDot optically stimulated luminescence (OSL) dosimeter was studied for the dosimetry of 6, 9, 12, 16, and 20 MeV therapeutic electron beams. With reference to ionization chamber, no change in the response was observed with the change in the energy of electron beams for the field size from 6 cm × 6 cm to 25 cm × 25 cm, dose rates from 100 MU/min to 600 MU/min, and the linearity in the response up to 300 cGy. The fading of the transient signal was higher for 20 MeV electron beam than that of 6 MeV electron beam by about 5% as compared to value at 20 min after irradiation. The depletion of OSL signal per readout in 200 successive readouts was also found to change with dose and energy of electron beam from 6 MeV (9% and 12% per readout at 2 and 10 Gy, respectively) to 20 MeV (9% and 16% at 2 and 10 Gy, respectively). The OSL sensitivity changed in the range from 2% to 6% with accumulated doses from 2 to 8 Gy and with electron energy from 6 to 20 MeV, but the sensitivity could be reset using an optical annealing treatment. Although negligible fading for postirradiation storage from 20 min to several months, acceptable precision and linearity in the desired range, and high reproducibility makes nanoDot dosimeters very attractive for the dosimetry of therapeutic electron beams, a note should be made for changes in sensitivity at doses beyond 2 Gy and electron beams energy dependence in reuse, short-term fading, and signal depletion on repeated readout.

Comparative dose levels between CT-scanner and slot-scanning device (EOS system) in pregnant women pelvimetry

PurposeTo estimate fetal absorbed doses for pregnant women pelvimetry, a comparative study between EOS imaging system and low-dose spiral CT-scanner was carried out. For this purpose three different studies were investigated: in vivo, in vitro and Monte Carlo calculations. MethodsIn vivo dosimetry was performed, using OSL NanoDot dosimeters, to determine the dose to the skin of twenty pregnant women. In vitro studies were established by using a cubic phantom of water, in order to estimate the out of field doses. In the latter study, OSLDs were placed at depths corresponding to the lowest, average and highest position of the uterus. Monte Carlo calculations of effective doses to high radio-sensitive organs were established, using PCXMC and CTExpo software suites for EOS imaging system and CT-scanner, respectively. ResultsThe EOS imaging system reduces radiation exposure 4 to 8 times compared to the CT-scanner. The entrance skin doses were 74% (p-values <0.01) higher with the CT-scanner than with the EOS system. In the out of field region, the measured doses of the EOS system were reduced by 80% (p-values <0.02).Monte Carlo calculations confirmed that effective doses to organs are less accentuated for EOS than for CT pelvimetry. ConclusionsThe EOS system is less irradiating than the CT exam. The out-of-field dose which is significant, is lower in the EOS than in the CT-scanner and could be reduced even further by optimizing the time used for image acquisition.